Journal Article

What should cardiologists be telling general practitioners/family physicians?

F.D.R. Hobbs

in European Heart Journal Supplements

Published on behalf of European Society of Cardiology

Volume 4, issue suppl_F, pages F54-F59
Published in print September 2002 | ISSN: 1520-765X
Published online September 2002 | e-ISSN: 1554-2815 | DOI: http://dx.doi.org/10.1016/S1520-765X(02)90030-1
What should cardiologists be telling general practitioners/family physicians?

Show Summary Details

Preview

Within the next 20 years cardiovascular disease is expected to become the leading cause of premature death and overall mortality worldwide. Because cardiovascular disease is multifactorial in nature, global risk assessment is required. Treatments for cardiovascular disease are among the most evidence-based therapies available to clinicians, and evidence of treatment benefit has resulted in clear guidelines regarding which interventions to use. Nevertheless, there is considerable variation within health care systems with regard to the diagnosis, management and follow-up of patients with cardiovascular disease. Two recent European surveys, conducted among patients and physicians, have provided evidence of factors that may contribute to this variability in clinical performance.

Keywords: Cardiovascular disease; global risk assessment; REACT surveys

Journal Article.  0 words. 

Subjects: Cardiovascular Medicine

Full text: subscription required

How to subscribe Recommend to my Librarian

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.